JP Morgan Chase report focuses on life science sector in 2021
JPMorgan Chase & Company recently released its “Life Sciences Outlook 2021” report.
Peter Meath, Co-Head of Healthcare and Life Sciences for Commercial Banking, notes that investment in life sciences reached record-high levels across almost every category and subsector in spite of unprecedented business challenges.
The report examines categories including biotech and biopharma, tools and diagnostics, pharma services, healthcare information technology, and medical devices.
